Invesaro

Stocks RNST Financial statements

Financial statements

RENASANT CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RENASANT CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Interest expense28.137.965.398.971.344.760.5278
Pre-tax income136160189216103223211177245227
Income tax44.867.741.748.119.846.945.232.549.545.5
Net income90.992.214716883.7176166145195181
EPS, basic2.181.972.802.891.493.132.972.583.292.09
EPS, diluted2.171.962.792.881.483.122.952.563.272.07
Shares, basic (weighted)41.746.952.55856.356.155.956.159.486.9
Shares, diluted (weighted)424752.658.256.556.456.256.459.787.5
Dividend per share0.710.730.800.870.880.880.880.880.880.89

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents3062815694156331,8785768011,0921,071
Property, plant and equipment179183209310300293284283
Lease right-of-use assets84.86663.554.948.546.855.9
Goodwill4716119339409409409929929891,406
Intangible assets24.124.544.937.330.124.124.218.814.1147
Total assets8,7009,83012,93513,40114,93016,81016,98817,36118,03526,751
Short-term debt11089.838848921.313.9712308108556
Total liabilities7,4678,31510,89111,27512,79714,60014,85215,06315,35722,867
Total debt202208264377475471428429431500
Paid-in capital7078981,2891,2941,2971,3001,3021,3081,4922,393
Retained earnings3383975016176167428589521,0941,197
Treasury stock-21.7-19.9-24.2-83.2-102-118-112-105-97.2-103
Other comprehensive income-15.9-10.5-17.90.7625.1-10.4-209-154-143-89.7
Shareholders' equity1,2331,5152,0442,1262,1332,2102,1362,2972,6783,885
Total equity1,2331,5152,0442,1262,1332,2102,1362,2972,6783,885
Total liabilities and equity8,7009,83012,93513,40114,93016,81016,98817,36118,03526,751
Shares outstanding44.349.358.556.956.255.85656.163.694.6

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income90.992.214716883.7176166145195181
Depreciation and amortization3.094.833.58.1934.647.442.735.232.316.2
Stock-based compensation3.125.297.2510.210.610.111.513.713.917.7
Deferred income tax1137.916.420-13.711.42.28-5.014.651.69
Cash from operations16420782.116482.2143574149106271
Capital expenditures-13.6-13-22.4-35-28.3-20.5-14.8-21.6-13.6-33.7
Acquisitions0-12100
Purchases of investments-140-210-687-492-516-2,108-713-11.9-174-1,201
Sales and maturities of investments15816916126243845838614988.8311
Cash from investing-35269.7-503-506-1,266-660-2,044-55.4-275-734
Debt issued98.40015098.319700
Debt repaid-47.2-170-0.85-35.4-0.17-203-32.4-2.68-0.25-60
Stock issued84.10000
Share buybacks00-7.06-62.9-24.6-21.3000-13.3
Dividends paid-29.7-34.4-43.6-50.9-50.1-50-50-50.3-53.7-78.6
Cash from financing283-3017091881,4021,762168132459441
Net change in cash94.7-24.8288-1542181,245-1,302225291-21.3
Free cash flow15019459.81295412255912792.8238
Interest paid25.936.966.798.473.745.754.6240381443
Income taxes paid22.732.624.526.7405141.84229.118.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $40.35 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Effective tax rate19.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)8.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.2%Net income / average total assets.

Growth

MetricValueHow it is calculated
Net income growth, 1y-7.3%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y3.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y16.7%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-36.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-11.1%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y6.9%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y155.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-22.1%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y27.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y156.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-24.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y34.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y1.1%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.4%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y0.2%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y45.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y22.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y12.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y48.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y16.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y12.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y46.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y15.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y9.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Debt / equity0.21xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets2.9%Total debt / total assets.
Liabilities / assets85.7%Total liabilities / total assets.
Net debt-$84.7MTotal debt - cash - short-term investments. Negative means more cash than debt.
Goodwill and intangibles / assets5.8%(Goodwill + intangible assets) / total assets.
Tangible book value$2.32BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
FCF conversion128.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow7.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.41Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share$4.37Free cash flow / diluted weighted shares.
Operating cash flow per share$4.71Cash from operations / diluted weighted shares.
Book value per share$42.35Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$25.34Tangible book value / shares outstanding.
Cash per share$9.64(Cash + short-term investments) / shares outstanding.
Payout ratio27.7%Dividends paid / net income, when net income is positive.
Dividends / FCF21.6%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$3.69BShare price x shares outstanding.
Enterprise value$3.60BMarket cap + total debt - cash - short-term investments.
P/E11.7xMarket cap / net income. Only when net income is positive.
P/B0.95xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.59xMarket cap / tangible book value, when positive.
P/FCF9.14xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.49xMarket cap / cash from operations, when positive.
EV/FCF8.93xEnterprise value / free cash flow, when both are positive.
FCF yield10.9%Free cash flow / market cap.
Earnings yield8.5%Net income / market cap (the inverse of P/E).
Dividend yield2.4%Dividends paid over the period / market cap.
Shareholder yield2.4%(Dividends paid + share buybacks) / market cap.
Was RENASANT CORP profitable in fiscal 2025?

Yes. Net income was $181.3M, a net margin of -.

How much free cash flow did RENASANT CORP generate in fiscal 2025?

Cash from operations of $271.5M minus capital expenditures of $33.7M left free cash flow of $237.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to RENASANT CORP